« Promote and support research on diabetes
and metabolic diseases. »
For the advancement of diabetes research
THE FFRD 2023 ACCOUNTS PUBLISHED!
The FFRD has just had its accounts validated by our auditor.
The activity reports for 2023 are available:
The FFRD will have the pleasure to meet you at the 60th EASD congress which will take place in Madrid, from September 9th to 13th.…
Approal of the FFRD’s strategic directions
Approval of accounts certified by our statutory auditor
Renewal of our partnerships and donors
Follow-up of projects and agreements of the recipients
Replacement of the treasurer
Deadline for submitting applications for the FFRD 2024 call for projects
(May 21, 11:59pm)
Diabetes mellitus affects 5% of the French population and is a major burden for the persons living with this chronic disease, with potentially serious complications and high costs induced. Major and continuous improvements have been made for a botter understanding of the mechanisms of the disease and its complications, and for its monitoring and treatment as well.
The FFRD supports clinical, basic, and translational research.
The supported basic research projects address major themes of type 1 and type 2 diabetes
covering subjects such as pancreatic beta cells, insulin resistance, and intestinal microbiota.
The clinical research projects, on the other hand, address the themes of type 1 and type 2 diabetes, as well as gestational diabetes
and often involve large multicenter cohort studies.
Since 2013, the Foundation has been:
